SKI Market

Indian Indices

Nifty

25,355.25 -120.85
(-0.47%)

Sensex

83,190.28 -345.80
( -0.41%)

Bank Nifty

56,956.00 -257.55
( -0.45%)

Nifty IT

38,376.65 -304.20
( -0.79%)

Global Indices

Nasdaq

44,477.29 215.52
(0.49%)

Dow Jones

6,283.97 37.45
(0.60%)

Hang Seng

39,601.95 -219.33
(-0.55%)

Nikkei 225

8,867.02 12.84
(0.15%)

Forex

USD-INR

85.73 -0.06
(-0.07%)

EUR-INR

100.55 -0.15
(-0.15%)

GBP-INR

116.58 -0.23
(-0.19%)

JPY-INR

0.59 0.00
(-0.73%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Aarey Drugs & Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

524412

INE198H01019

48.9464696

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AAREYDRUGS

49.43

199.02

EPS(TTM)

Face Value()

Div & Yield %

1.42

Particulars(INCOME)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)	Mar 2019 ( Cr)
Sales Turnover	395.62	418.96	492.76	348.42	300.09	354.74
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	395.62	418.96	492.76	348.42	300.09	354.74
Other Income	6.96	2.73	2.67	7.01	6.69	4.34
Stock Adjustments	5.86	15.14	-4.77	1.46	-4.25	6.48
Total Income	408.44	436.83	490.66	356.89	302.53	365.56
EXPENDITURE :
Raw Materials	387.76	418.98	461.35	335.96	285.93	347.45
Power & Fuel Cost	0.03	0.03	0.04	0.00	0.01	0.04
Employee Cost	0.54	0.63	0.67	0.20	0.29	0.37
Other Manufacturing Expenses	0.60	1.50	7.15	4.99	1.31	1.65
Selling & Administrative Expenses	7.83	4.52	6.89	3.88	4.94	3.82
Miscellaneous Expenses	0.26	0.71	0.50	0.20	0.12	0.01
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	397.03	426.37	476.60	345.23	292.61	353.33
Operating Profit	11.42	10.45	14.07	11.66	9.93	12.22
Interest	4.38	2.87	2.04	2.44	1.79	2.23
Gross Profit	7.04	7.58	12.03	9.22	8.14	9.99
Depreciation	1.70	1.57	1.99	0.92	0.89	1.01
Profit Before Tax	5.34	6.01	10.04	8.30	7.25	8.98
Tax	1.33	2.28	3.59	1.66	1.50	2.25
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-0.67	-0.04	-0.11	0.12	-0.05	0.19
Reported Net Profit	4.68	3.77	6.55	6.51	5.79	6.54
Extraordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Net Profit	4.68	3.77	6.55	6.51	5.79	6.54
Adjustment below Net Profit	0.00	0.00	-0.01	0.00	0.00	0.00
P & L Balance brought forward	48.42	44.65	38.11	31.59	25.80	19.49
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	0.00	0.00	0.23
P & L Balance carried down	53.11	48.42	44.65	38.11	31.59	25.80
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	1.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	0.10
Earnings Per Share-Unit Curr	1.67	1.49	2.58	2.79	2.48	2.80
Earnings Per Share(Adj)-Unit Curr	1.67	1.49	2.58	2.79	2.48	2.80
Book Value-Unit Curr	45.57	44.43	43.85	41.29	38.50	36.02
Book Value(Adj)-Unit Curr	45.57	44.43	43.85	41.29	38.50	36.02

25,355.25 -120.85 (-0.47%)

83,190.28 -345.80 ( -0.41%)

56,956.00 -257.55 ( -0.45%)

38,376.65 -304.20 ( -0.79%)

44,477.29 215.52 (0.49%)

6,283.97 37.45 (0.60%)

39,601.95 -219.33 (-0.55%)

8,867.02 12.84 (0.15%)

85.73 -0.06 (-0.07%)

100.55 -0.15 (-0.15%)

116.58 -0.23 (-0.19%)

0.59 0.00 (-0.73%)